LWANC
TMO icon

Laurel Wealth Advisors (North Carolina)’s Thermo Fisher Scientific TMO Stock Holding History

Laurel Wealth Advisors (North Carolina)’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-72
Closed -$41.7K – 600
2025
Q4 		$41.7K Buy
+72
New +$40.7K 0.01% 343
2025
Q2 		– Sell
-104
Closed -$51.8K – 618
2025
Q1 		$51.8K Hold
104
– – 0.01% 308
2024
Q4 		$54.1K Sell
104
-11
-10% -$6.05K 0.01% 303
2024
Q3 		$71.1K Hold
115
– – 0.01% 275
2024
Q2 		$63.6K Sell
115
-15
-12% -$8.59K 0.01% 271
2024
Q1 		$75.6K Buy
130
+32
+33% +$18K 0.01% 256
2023
Q4 		$52K Hold
98
– – 0.01% 278
2023
Q3 		$49.6K Hold
98
– – 0.01% 275
2023
Q2 		$51.1K Hold
98
– – 0.01% 280
2023
Q1 		$56.5K Hold
98
– – 0.01% 269
2022
Q4 		$54K Hold
98
– – 0.01% 252
2022
Q3 		$50K Buy
98
+11
+13% +$6.16K 0.01% 254
2022
Q2 		$47K Sell
87
-38
-30% -$20.9K 0.01% 262
2022
Q1 		$74K Hold
125
– – 0.02% 246
2021
Q4 		$83K Buy
125
+15
+14% +$9.37K 0.02% 234
2021
Q3 		$63K Hold
110
– – 0.01% 255
2021
Q2 		$55K Buy
110
+15
+16% +$7.08K 0.01% 270
2021
Q1 		$43K Hold
95
– – 0.01% 282
2020
Q4 		$44K Buy
95
+24
+34% +$11.3K 0.01% 269
2020
Q3 		$31K Hold
71
– – 0.01% 279
2020
Q2 		$26K Sell
71
-23
-24% -$7.71K 0.01% 288
2020
Q1 		$27K Buy
94
+48
+104% +$15.1K 0.01% 269
2019
Q4 		$15K Hold
46
– – ﹤0.01% 350
2019
Q3 		$13K Buy
46
+22
+92% +$6.3K ﹤0.01% 355
2019
Q2 		$7K Sell
24
-22
-48% -$6.06K ﹤0.01% 408
2019
Q1 		$13K Hold
46
– – ﹤0.01% 342
2018
Q4 		$10K Buy
+46
New +$10.8K ﹤0.01% 356

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Laurel Wealth Advisors (North Carolina)'s TMO Position: Q1 2026 in Review

Laurel Wealth Advisors (North Carolina) sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 72 shares — an estimated $41.7K sold.

Laurel Wealth Advisors (North Carolina) first reported a position in TMO in Q4 2018 and held it in 27 quarters. The position peaked at $83K in Q4 2021. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Laurel Wealth Advisors (North Carolina) reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • Laurel Wealth Advisors (North Carolina) sold 72 Thermo Fisher Scientific shares in Q1 2026, an estimated $41.7K.
  • Laurel Wealth Advisors (North Carolina) first reported a position in Thermo Fisher Scientific in Q4 2018 and held it in 27 quarters.
  • Laurel Wealth Advisors (North Carolina)'s Thermo Fisher Scientific position peaked at $83K in Q4 2021.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Laurel Wealth Advisors (North Carolina)'s 13F filing for Q1 2026, filed 13 May 2026.